Literature DB >> 29785656

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.

Annika M Bruger1, Anca Dorhoi2, Gunes Esendagli3, Katarzyna Barczyk-Kahlert4, Pierre van der Bruggen1, Marie Lipoldova5, Tomas Perecko6, Juan Santibanez7,8, Margarida Saraiva9,10, Jo A Van Ginderachter11,12, Sven Brandau13.   

Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of mononuclear and polymorphonuclear myeloid cells, which are present at very low numbers in healthy subjects, but can expand substantially under disease conditions. Depending on disease type and stage, MDSC comprise varying amounts of immature and mature differentiation stages of myeloid cells. Validated unique phenotypic markers for MDSC are still lacking. Therefore, the functional analysis of these cells is of central importance for their identification and characterization. Various disease-promoting and immunosuppressive functions of MDSC are reported in the literature. Among those, the capacity to modulate the activity of T cells is by far the most often used and best-established read-out system. In this review, we critically evaluate the assays available for the functional analysis of human and murine MDSC under in vitro and in vivo conditions. We also discuss critical issues and controls associated with those assays. We aim at providing suggestions and recommendations useful for the contemporary biological characterization of MDSC.

Entities:  

Keywords:  Arginase; Immunosuppression; Mye-EUNITER; Myeloid-derived suppressor cells; Proliferation; T cells

Mesh:

Substances:

Year:  2018        PMID: 29785656     DOI: 10.1007/s00262-018-2170-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  35 in total

1.  CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer.

Authors:  Utku Horzum; Digdem Yoyen-Ermis; Ekim Z Taskiran; Kerim Bora Yilmaz; Erhan Hamaloglu; Derya Karakoc; Gunes Esendagli
Journal:  Cancer Immunol Immunother       Date:  2020-07-06       Impact factor: 6.968

Review 2.  Neutrophil Diversity in Health and Disease.

Authors:  Carlos Silvestre-Roig; Zvi G Fridlender; Michael Glogauer; Patrizia Scapini
Journal:  Trends Immunol       Date:  2019-05-31       Impact factor: 16.687

3.  Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.

Authors:  Sara Falck-Jones; Sindhu Vangeti; Meng Yu; Ryan Falck-Jones; Alberto Cagigi; Isabella Badolati; Björn Österberg; Maximilian Julius Lautenbach; Eric Åhlberg; Ang Lin; Rico Lepzien; Inga Szurgot; Klara Lenart; Fredrika Hellgren; Holden Maecker; Jörgen Sälde; Jan Albert; Niclas Johansson; Max Bell; Karin Loré; Anna Färnert; Anna Smed-Sörensen
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

4.  Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood; Joanna Hester; Fadi Issa
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

5.  Cysteine cathepsins L and X differentially modulate interactions between myeloid-derived suppressor cells and tumor cells.

Authors:  Tanja Jakoš; Anja Pišlar; Urša Pečar Fonović; Urban Švajger; Janko Kos
Journal:  Cancer Immunol Immunother       Date:  2020-05-05       Impact factor: 6.968

6.  [Research Progress of Cancer-associated Fibroblasts in Lung Cancer].

Authors:  Chongbiao Huang; Jie Xu; Zengxun Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-04-20

Review 7.  Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.

Authors:  Kyoko Oura; Asahiro Morishita; Joji Tani; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 8.  Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.

Authors:  Jarupa Soongsathitanon; Pranisa Jamjuntra; Nuttavut Sumransub; Supaporn Yangngam; Marjorie De la Fuente; Glauben Landskron; Peti Thuwajit; Marcela A Hermoso; Chanitra Thuwajit
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

9.  Low-Density Neutrophils in Healthy Individuals Display a Mature Primed Phenotype.

Authors:  Carlos Blanco-Camarillo; Omar Rafael Alemán; Carlos Rosales
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

Review 10.  Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.

Authors:  Qinjun Chen; Tao Sun; Chen Jiang
Journal:  Nanomicro Lett       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.